ArticleClinical kidney journal2023

Rationale and design of CONTINUITY: a Phase 4 randomized controlled trial of continued post-discharge sodium zirconium cyclosilicate treatment versus standard of care for hyperkalemia in chronic kidney disease.

James O Burton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.